List of Tables
Table 1. Global Orally Administered Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Orally Administered Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Orally Administered Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Orally Administered Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Orally Administered Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Orally Administered Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Orally Administered Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Orally Administered Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Orally Administered Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orally Administered Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Administered Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Orally Administered Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Administered Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Administered Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Administered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Orally Administered Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Orally Administered Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Orally Administered Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Orally Administered Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Orally Administered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Orally Administered Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Orally Administered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Orally Administered Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Orally Administered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Orally Administered Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Orally Administered Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Orally Administered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Orally Administered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Orally Administered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Orally Administered Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Orally Administered Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Orally Administered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Orally Administered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Orally Administered Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Orally Administered Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Orally Administered Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Orally Administered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Orally Administered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Orally Administered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Orally Administered Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Orally Administered Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Orally Administered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Orally Administered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Orally Administered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Orally Administered Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Orally Administered Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Orally Administered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Orally Administered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Orally Administered Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Orally Administered Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Orally Administered Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Orally Administered Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Orally Administered Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Orally Administered Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Orally Administered Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Orally Administered Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Orally Administered Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Orally Administered Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Orally Administered Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Orally Administered Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Orally Administered Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Orally Administered Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Orally Administered Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Orally Administered Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Orally Administered Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Orally Administered Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Orally Administered Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Orally Administered Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Orally Administered Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Orally Administered Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Orally Administered Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Company Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lanzhou Institute Orally Administered Vaccine Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Company Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Serum Institute Orally Administered Vaccine Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Company Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Orally Administered Vaccine Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Company Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Orally Administered Vaccine Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Company Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bibcol Orally Administered Vaccine Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Company Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. PaxVax Orally Administered Vaccine Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Company Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Vabiotech Orally Administered Vaccine Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Company Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tiantan Biological Orally Administered Vaccine Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Company Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. EuBiologics Orally Administered Vaccine Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Company Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Panacea Biotec Ltd Orally Administered Vaccine Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Company Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bio-Med Orally Administered Vaccine Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Company Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Orally Administered Vaccine Distributors List
Table 148. Orally Administered Vaccine Customers List
Table 149. Orally Administered Vaccine Market Trends
Table 150. Orally Administered Vaccine Market Drivers
Table 151. Orally Administered Vaccine Market Challenges
Table 152. Orally Administered Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Orally Administered Vaccine
Figure 2. Global Orally Administered Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Orally Administered Vaccine Market Share by Type: 2024 & 2031
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Orally Administered Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Orally Administered Vaccine Market Share by Application: 2024 & 2031
Figure 10. Public
Figure 11. Private
Figure 12. Global Orally Administered Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Orally Administered Vaccine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Orally Administered Vaccine Sales (2020-2031) & (K Units)
Figure 15. Global Orally Administered Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 16. Orally Administered Vaccine Report Years Considered
Figure 17. Orally Administered Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Orally Administered Vaccine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Orally Administered Vaccine Players: Market Share by Revenue in Orally Administered Vaccine in 2024
Figure 20. Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Orally Administered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Orally Administered Vaccine Sales Market Share by Country (2020-2031)
Figure 23. North America Orally Administered Vaccine Revenue Market Share by Country (2020-2031)
Figure 24. United States Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Orally Administered Vaccine Sales Market Share by Country (2020-2031)
Figure 27. Europe Orally Administered Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Orally Administered Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Orally Administered Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. China Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Orally Administered Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Orally Administered Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Orally Administered Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Orally Administered Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Orally Administered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Orally Administered Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Orally Administered Vaccine by Type (2020-2031)
Figure 54. Global Orally Administered Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Orally Administered Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Orally Administered Vaccine by Application (2020-2031)
Figure 57. Global Orally Administered Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 58. Orally Administered Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
